Paper Details

  1. Home
  2. Paper Details

Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis.

Author: HouJie, LiJia, SuSen-Sen, XueShuai, ZhangLi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This meta-analysis assesses the efficacy and safety of roxadustat in treating anemia associated with chronic kidney disease.
Paper Details　
Original Abstract of the Article :
Anemia is a common complication of chronic kidney disease (CKD). Treating renal anemia with erythropoiesis-stimulating agents (ESAs) or erythropoietin analogs is effective but has side effects. Therefore, we performed a meta-analysis to assess the efficacy and safety of roxadustat in treating CKD-in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312415/

データ提供：米国国立医学図書館（NLM）

Roxadustat: A Promising Treatment for Anemia in CKD Patients?

The field of chronic kidney disease (CKD) is constantly evolving, and researchers are always seeking new ways to improve the lives of patients. One of the most common complications of CKD is anemia, which can significantly impact quality of life. Traditional treatments, such as erythropoiesis-stimulating agents (ESAs), have been effective, but they can also have side effects. This study explored the potential of roxadustat, a novel drug, as a treatment for CKD-induced anemia. Using a meta-analysis, the researchers assessed the efficacy and safety of roxadustat in treating this complex condition.

Exploring Roxadustat's Effectiveness

The results of this meta-analysis suggest that roxadustat holds promise as a treatment for anemia in CKD patients. While more research is needed, this study provides encouraging evidence that roxadustat could offer an alternative to existing treatments with potentially fewer side effects.

New Hope for CKD Patients?

The potential benefits of roxadustat for CKD patients with anemia are exciting. This research highlights the importance of finding new and effective treatments for this widespread condition.

Dr.Camel's Conclusion

This meta-analysis sheds light on the potential of roxadustat as a safe and effective treatment for anemia in CKD patients. It's like finding a refreshing oasis in the vast desert of CKD research, offering hope for improved health and quality of life for those struggling with this condition. However, as with any new treatment, continued research is crucial to fully understand its long-term benefits and potential risks.

Date :
  1. Date Completed 2021-08-04
  2. Date Revised 2022-01-11
Further Info :

Pubmed ID

34115611

DOI: Digital Object Identifier

PMC8312415

Related Literature

Article Analysis
・Effective treatment of kidney diseases
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.